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The interactions between intestinal microbiota, immune system, and pathogens describe
the human gut as a complex ecosystem, where all components play a relevant role
in modulating each other and in the maintenance of homeostasis. The balance among
the gut microbiota and the human body appear to be crucial for health maintenance.
Intestinal parasites, both protozoans and helminths, interact with the microbial community
modifying the balance between host and commensal microbiota. On the other hand,
gut microbiota represents a relevant factor that may strongly interfere with the
pathophysiology of the infections. In addition to the function that gut commensal
microbiota may have in the processes that determine the survival and the outcome
of many parasitic infections, including the production of nutritive macromolecules, also
probiotics can play an important role in reducing the pathogenicity of many parasites.
On these bases, there is a growing interest in explaining the rationale on the possible
interactions between the microbiota, immune response, inflammatory processes, and
intestinal parasites.
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THE HUMAN INTESTINAL MICROBIOTA
The human gut represents a complex ecosystem composed by
a large microbial community associated with the human body
(Human Microbiome Project Consortium, 2012). The species
composition varies greatly between individuals, with each indi-
vidual harboring a unique collection of bacterial species, which
may change over time (Bäckhed et al., 2005; Eckburg et al.,
2005; Qin et al., 2010). Genetic factors play an important role in
gut microbiota development, although environment also drives
species acquisition (Zoetendal et al., 2001). Recently, the human
body together with its gut microbiota has been referred to as a
“superorganism” where an extensive coordination of metabolic
and physiological processes occurs (Nicholson et al., 2004). The
presence of the intestinal microbiota enriches the human organ-
ism with important functions, particularly in regulating host
fat storage (Bäckhed et al., 2004), stimulating intestinal epithe-
lium renewal (Rakoff-Nahoum et al., 2004), and influencing the
maturation of the immune system (Mazmanian et al., 2005).
As recently reviewed (Sekirov et al., 2010; Clemente et al.,
2012), the balance among the gut microbiota and the human
body is crucial for health maintenance, and perturbation of
microbial composition has been supposed to be involved in a
range of diseases (Bäckhed et al., 2005; Palming et al., 2006).
Moreover, the commensal microbiota contributes to the “barrier
effect” of the intestinal epithelium, which plays the primary role
of protecting the host, representing a real obstacle to pathogens
invasion (Bancroft et al., 2012). Within this complex scenario,
intestinal parasites interact with the microbial community mod-
ifying the balance between host and gut microbiota. Each of
these organismsmetabolizes andmodifies substrates interactively.
Resident microbiota products may strongly interfere with the sur-
vival and the physiology of many parasites and, consequently,
with the outcome ofmany parasitic infections. On the other hand,
intestinal parasites, both protozoans and helminths, constantly
excrete and secrete molecules that may change the environment
determining alterations in gut microbiota compositions. Also
part of the energy extracted from nutrient metabolism by res-
ident microbes may be beneficial not only to the host (Sekirov
et al., 2010) but also to parasitic organisms eventually present. It
is therefore pertinent to consider the intestinal environment as
an ecosystem where biological and chemical interactions occur at
various organizational levels between host, parasites, and micro-
bial communities (Nicholson et al., 2004; Bancroft et al., 2012).
PROTOZOANS
A wide range of protozoans are common parasites of human
gastro-intestinal tract. They are a not homogenous group and
their physiology and biochemistry are largely geared to the par-
asitic habit. They show different mechanisms of host invasion,
some are intracellular (e.g., Cryptosporidium spp.) and host spe-
cialized (e.g., Entamoeba histolytica), many of them are adapted
to more than one host (e.g., Giardia duodenalis). Few species do
any real damage but some occasionally give rise to symptoms
that usually include diarrhea related to damage in the wall of the
bowel.
Among protozoans, the species G. duodenalis could represent a
good model to highlight some mechanisms related to the existing
interactions with the intestinal microbiota. This flagellate is rec-
ognized as one of the most common pathogenic gastrointestinal
parasites in humans and in a wide range of animals (Thompson,
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2000). The spectrum of clinical manifestations varies from a mild
self-limiting illness to acute or chronic diarrhea and weight loss,
with malabsorption lasting for several months (Farthing, 1996).
Furthermore, people may be infected without any symptoms.
The causes determining this variability in clinical picture are still
poorly understood.
Numerous studies assessed that pathogenesis results from
interaction between parasite products, such as proteinases that
break the epithelial barrier, and host inflammatory and immuno-
logical responses as observed for Cryptosporidium (Chai et al.,
1999; Guk et al., 2003) as well as for Giardia (Scott et al., 2004;
Ankarklev et al., 2010). Recognition of protozoans parasitiz-
ing mucosal surfaces may involve innate immune system, e.g.,
toll-like receptors (TLRs), as demonstrated in vivo on infected
humans for Trichomonas vaginalis (Zariffard et al., 2004), and
in vitro on human monocytes for E. histolytica (Maldonado et al.,
2000). Moreover, T cells (particularly involving CD8+ cells),
macrophages, neutrophiles, and antibodies (IgM, IgG, and IgA)
are major players of the acquired immune response necessary for
the resolution of giardiasis.
PROTOZOAN INFECTION AND GUT MICROBIOTA
Gut microbiota represents an additional factor that may strongly
interfere with the pathophysiology of the parasite infections.
However, the existing interactions between the enteric flora and
protozoan parasites are still poorly understood.
Based on mouse models, normal intestinal flora was shown to
decrease susceptibility to infection by Cryptosporidium parvum
(Harp et al., 1992). Conversely, in other studies, the presence of
gut microbiota seems to be essential for the pathogenic expression
of other enteric protozoans such as E. histolytica (Phillips et al.,
1955), Blastocystis hominis (Phillips and Zierdt, 1976), and differ-
ent species of Eimeria (Visco and Burns, 1972; Owen, 1975; Gouet
et al., 1984).
Different hypotheses have been proposed to explain the mech-
anisms involved in this pathogenic stimulation by bacteria. Some
of them are related to changes caused by axenisation of the
protozoans. In this case, the surface saccharide ligands of the
superficial membrane are altered by the presence of intracel-
lular bacterial symbionts, so that in axenic protozoa cured of
their endosymbionts, a possible decrease in adhesion or in inva-
sive abilities can be observed (Phillips, 1973; Dwyer and Chang,
1976). Also inGiardia, in the past decade, ultrastructural observa-
tions of Giardia muris in a murine model revealed endosymbiotic
microbes which, according to the authors, could be related to
variation in the trophozoite pathogenicity, metabolism, range
of infectivity, antigenic surface characteristics, and host speci-
ficity (Nemanic et al., 1979). More recently, the presence of
Giardia trophozoites harboring peripheral bacterial endosym-
bionts was also demonstrated by El-Shewy and Eid (2005). Based
on TEM examination, the authors found that only tropho-
zoites with endosymbionts were lysed when in close vicinity
of the activated Paneth cells, confirming the host protective
role of the bacterial endosymbionts within Giardia tropho-
zoites and further supporting the idea that gut microbiota
may directly and indirectly interfere in the pathogenesis of
giardiasis.
Similarly intriguing is the idea that axenisation of the host at
the intestinal level can be involved in the virulence expression of
protozoan parasites. Working with E. histolytica, Mirelman and
colleagues (1982, 1983) evidenced that interactions of amoebae
of low pathogenicity with a variety of Gram-negative bacte-
ria, mainly Escherichia coli strains, may be responsible for the
increase in amoebic virulence. More recently, Galván-Moroyoqui
et al. (2008) demonstrated that phagocytosis of enteropathogenic
bacteria strains (e.g., E. coli and Shigella dysenteriae) in vitro
co-cultured with E. histolytica and Entamoeba dispar augmented
the cytopathic effect of E. histolytica and increased expression
of Gal/GalNAc lectin on the amoebic surface and the cysteine
proteinase activity. E. dispar remained avirulent.
Also for G. duodenalis, several studies have shown that the
intestinal microbiota can stimulate the pathogenic expression but
not the multiplication of parasites (Torres et al., 1992, 2000). In
a gnotobiotic animal model, Torres et al. (2000) provided evi-
dence that the bacteria responsible for part of the stimulation
of G. duodenalis pathogenicity are present in the dominant duo-
denal microbiota. In this work, facultative and strictly anaerobic
micro-organisms of the duodenal microbiota were obtained from
biopsy of five children with symptomatic giardiasis and tested for
their ability to stimulate G. duodenalis pathogenicity in gnotox-
enic mice. Quantification of cysts in faeces and of trophozoites in
the small bowel was also performed to evaluate protozoan mul-
tiplication in the different groups of mice. As observed, germ-
free animals did not develop intestinal pathological modifications
during experimental Giardia infection; infected gnotoxenic mice
showed intermediate pathological alterations between germ-free
and infected conventionalmice used as controls; finally, no patho-
logical changes were observed in non-infected gnotoxenic or
conventional animals. According to the authors, these results sup-
port the hypothesis that, as demonstrated also for other intestinal
pathogenic protozoans, bacterial components from the intestinal
microbiota represent stimulatory factors for Giardia pathogenic-
ity but not for protozoan multiplication since faecal cyst levels
remained similar among the three different groups of mice during
the experimental infection.
HELMINTHS
The intestine represents the ideal habitat for a large number
of parasitic worms. Among flatworms, cestodes of the genera
Diphyllobothrium, Taenia, and Hymenolepis and digeneans such
as Fasciolopsis, Heterophyes, and Schistosoma, live in close inter-
action with human gut mucosae and lumen. As for nematodes,
the most common intestinal roundworms are geohelminths
(Ascaris, Trichuris, Ancylostomatidae, and Strongyloides), as well
as Enterobius vermicularis.
While in less-favored areas, the interest in intestinal helminthi-
ases is mainly focused on the parasitic disease itself, in indus-
trialized countries the intimate relationships between intestinal
helminthes with gutmicrobiota and the putative down-regulation
of self-pathogenic immune response have been the object of
recent studies, as a consequence of the increasing concern regard-
ing childhood allergies, atopic dermatitis and asthma (Patel
et al., 2008), IBDs like Crohn’s disease and ulcerative colitis, and
autoimmune disorders (Weinstock and Elliott, 2009).
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HELMINTH INFECTION AND GUT MICROBIOTA
The human intestinal microbiota is essential in providing
nourishment, regulating epithelial development, and instructing
innate immunity (Eckburg et al., 2005). A significant variabil-
ity and differences between community compositions are often
described, all consistent with a picture of a highly diverse ecosys-
tem. It has been suggested that, in the course of helminth
infections, significant changes in the abundance and composi-
tion of gastrointestinal tract microbiota are observed. Intestinal
nematodes produce molecules that may alter the habitat for gut
microbiota. Walk et al. (2010) showed that infection of mice with
Heligmosomoides polygyrus, a parasite of the duodenum, induces
changes in composition of bacteria communities in the ileum but
not in the colon; themajority of bacteria within the infected ileum
were Lactobacillae species. Interestingly, H. polygyrus is able to
significantly reduce inflammation of colitis in mice (Elliott et al.,
2004) and to determine alterations in epithelial barrier function
in the colon (Su et al., 2011). Additionally, Li et al. (2012) demon-
strated a significant alteration in the colon microbiota of pigs
induced by Trichuris suis after 21 days from infection. As sug-
gested by Wu et al. (2012), the initial infection, even when not
followed by the persistence of the parasitosis, is able to determine
changes in the abundance of up to the 13% of genera detected, in
particular Fibrobacter and Ruminococcus.
A further major aspect related to the helminth infections is
the potential interaction between macrofauna, microflora, and
host immunity. It has been evidenced the overall decrease in
proinflammatory cytokines associated with chronic inflamma-
tion observed in the course of helminth infections; moreover,
autoimmune disorders have a reduced incidence in geographi-
cal regions where higher prevalence of parasitic infections are
reported (Sewell et al., 2002). Reddy (2010) argued that a reduced
exposure to pathogenic organisms in developed countries may
determine a minor stimulation of the immune system and an
increased incidence of autoimmune and allergic diseases in the
human populations. Based on several studies from developing
country settings, evidences have been provided for the role of
intestinal nematodes in the prevention of allergic responses (van
den Biggelaar et al., 2004; Summers et al., 2005a; Croese et al.,
2006; Leonardi-Bee et al., 2006; Flohr et al., 2009). This phe-
nomenon is known as “Hygiene hypothesis” (Wills-Karp et al.,
2001; Weinstock and Elliott, 2009). In particular, the interactions
between helminth infections and host immune system may prove
to be beneficial for both, the parasite and the host, with regard to
the control of autoimmune diseases (Maizels et al., 2009).
On this basis, there is a growing interest in explaining the ratio-
nale on the existing interactions between helminthes, gut micro-
biota and immune-mediated intestinal inflammatory status, e.g.,
in celiac patients, as recently reviewed by Bancroft et al. (2012).
The authors, focusing mainly on infections due to Trichuris sp.,
considered the immunomodulation by parasitic helminths and
the interaction between the microbiota and the immune system
in an integrated manner, where Th17 (T-helper) and Tregs (reg-
ulatory T cells) are affected by the action of microbiota, and are
in turn able to act on parasite survival. At the same time, parasitic
worms produce molecules that may alter the habitat for intestinal
microbiota.
Besides to nematodes, also digeneans such as Schistosomaman-
soni have been described to induce microbial disturbance. In
a metabonomic investigations in mice infected with S. man-
soni, Wang et al. (2004) reported several complex outcomes
to the metabolism disturbance due to Schistosoma infections,
including impaired liver functions, perturbation of amino acids
metabolism and of the tricarboxylic acid (TCA) cycle. Moreover,
high excretion of urinary trimethylamine, phenylacetylglycine,
and p-cresol glucuronide indicating disturbances in the gut
microbiota are found in S. mansoni-infected mice, proba-
bly due to an increased production from microbial agents
caused by alteration of the microbial ecosystem in the pres-
ence of the parasite. Analogous changes at the Nuclear Magnetic
Resonance (NMR) metabolic profiles have been detected dur-
ing the infections by Fasciola hepatica, Necator americanus, and
other human helminth parasites, as reviewed by Wang et al.
(2010).
Similarly, Balog et al. (2011), on the base of urinary response
of rodent and human hosts to S. mansoni infection, demonstrated
gross disturbance of metabolites associated with gut microbial
community and microbial co-metabolism and Li et al. (2011)
identified 12 urinary and five faecal metabolites as biomarkers
of Schistosoma infection, able to differentiate infected and not
infected mice, adding further evidence to the hypothesis that
S. mansoni infection either directly or indirectly modulates host
gut microbial activity.
NEMATODES AS A THERAPY
The positive results in the potential of therapeutic effect of worms
or their molecules in animals have led to several human studies
exploring presumptively harmless helminthes like T. suis, a whip-
worm that naturally infects pigs. Treatment of colitis patients with
T. suis ova provided promising results and such therapies are cur-
rently under development (Summers et al., 2005b). However, a
special attention should be paid to possible adverse effects. The
first concern regards the zoonotic potential of T. suis. The system-
atics of the group is still controversial and a clearcut delineation
of species infecting humans is actually under definition. The sec-
ond aspect is related to the possibility that T. suis infection may
play a role in the internalization of intestinal pig epithelial cells
by bacteria (e.g., Campylobacter jejuni) and subsequent bacterial
invasion (Wu et al., 2012). Finally, the effect of helminth infec-
tions on allergic diseases may vary depending on the parasite
species, as it has been proposed that different species may act
as immunosuppressant or as enhancers of allergic phenomena
(Pinelli, 2012).
PROBIOTICS AGAINST PARASITES
Probiotics may also be a factor that can potentially inhibit the
development of several pathogens. As reviewed by Travers et al.
(2011), probiotics demonstrated to be efficient for the treatment
of gastrointestinal disorders, respiratory infections, and allergic
symptoms, and also can kill or inhibit pathogens by strain-specific
mechanisms relying on competition, molecule secretion, and/or
immune induction. Several studies have reported the effects of
probiotics on parasites, both protozoans (e.g., Cryptosporidium,
Eimeria) and helminths (e.g., Ascaris, Trichuris).
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As regard Giardia, a large amount of data are now available,
since the first study of Singer and Nash (2000) who provided
preliminary evidences that the composition of the intestinal
flora was likely involved in the highly variable manifestations
in giardiasis in both humans and animals. Pérez et al. (2001)
studied the in vitro effect of different probiotic bacteria (six
Lactobacillus acidophilus strains, and Lactobacillus johnsonii La1)
on G. duodenalis strain WB trophozoites demonstrating that
only L. johnsonii La1 significantly inhibited the proliferation of
Giardia trophozoites. The activity of L. johnsonii La1 (NCC533)
was confirmed by Humen et al. (2005) in in vivo experiments
where a protection against parasite-induced mucosal damage
and a cellular response to Giardia antigens was stimulated in
spleen cells from La1-treated animals, leading to a resolution of
infection.
Moreover, Lactobacillus casei MTCC 1423 strain as well as
Enterococcus faecium SF68 were both effective in eliminating
Giardia infection in probiotic-fed mice by minimizing or pre-
venting the adherence of Giardia trophozoites to the mucosal
surface (Shukla et al., 2008) and stimulating an humoral response
(Benyacoub et al., 2005).
Recently, the effectiveness of different lactobacilli
species/strains to prevent and treat murine Giardia infection has
been further assessed by several authors (Shukla et al., 2009, 2010;
Goyal et al., 2011). The results obtained by Shukla and Sidhu
(2011) and Shukla et al. (2012) showing the positive effect of
L. casei in renourished Giardia intestinalis infected BALB/c mice
confirm the role of probiotics to reduce the duration and sever-
ity of giardiasis through the morphological and physiological
retrieval of the intestine.
As for worms, Bautista-Garfias et al. (2001) suggested that oral
treatment with L. casei appears to reduce the parasite burden
Trichinella spiralis in mice. Also Enterococcus faecalis CECT7121,
a probiotic with inhibitory activity against Gram-positive and
Gram-negative bacteria, possesses in vitro and in vivo larvici-
dal activity determining up to a 90% reduction of the number
of Toxocara canis larvae in liver and lungs of laboratory mice
(Basualdo et al., 2007; Chiodo et al., 2010). Zymomonas mobilis, a
bacterium producer of bioethanol, was reported to provide over
60% protection from the infection of S. mansoni in mice (Santos
Jde et al., 2004).
FUTURE PERSPECTIVES
The multidimensional linkages among human body, gut micro-
biota and parasites result in a complex ecosystem where alter-
ations in one of the these components determine a counter
response in the remaining ones. In this view, in order to achieve
an advanced understanding of the ongoing processes determining
the infections, an -omics approach which include comprehensive,
multidisciplinary and combined actions from these different per-
spectives is needed. Many outstanding questions require further
investigations, e.g., the existing interactions between the micro-
biota, immune response, inflammatory processes, and intestinal
parasitic diseases as well as the mechanisms regarding how pro-
biotics act against intestinal parasites and the possibility for their
therapeutic use for humans. Finally, new exciting areas such as the
study of the parasitome and the metabolome of gut microbiota
during chronic parasite infection and their relationship with host
immunoregulatory mechanisms have now to be approached in
the framework of an integrated approach.
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